Indivior (NASDAQ:INDV) Stock, Quote.Headers.trade-ideas

Indivior

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

INDV

Biotech

Earnings

News

Guidance

Eurozone

Health Care

Movers

Trading Ideas

General

Indivior&#39;s 2025 outlook missed estimates, citing Suboxone sales erosion. The company plans $100 million in cost cuts, with $50M reinvested in Sublocade.

European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat

Tesla Inc. (TSLA)

Pre-Market Outlook

Markets

HSAI

LILM

NYXH

TIGR

TSLA

Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday&#39;s Pre-Market Session

caution_wall_street

Equities

Commodities

Intraday Update

BLMZ

GRTS

S&amp;P Moves Lower; Domino&#39;s Pizza Posts Mixed Q3 Results

Indivior PLC

INDVR Brands Inc

Press Releases

Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024

Indivior Statement RE: Delayed FDA Approval of SUBLOCADE® Label Changes

Indivior Announces FY and Q4 2024 Financial Results

Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer

Indivior Announces Further Changes to Board of Directors

Indivior Announces Q1 2025 Financial Results

New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy

Indivior to Participate in Upcoming Investor Events

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

ANI Pharmaceuticals

BGM Group

Belite Bio, Inc - American Depositary Shares

Belite Bio

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cormedix

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences Hldgs

Harrow

Innoviva

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Liquidia

Ocular Therapeutix

Organon

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pacira BioSciences

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Supernus Pharmaceuticals, Inc. - Common Stock

Supernus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. - Common Stock

Tarsus Pharmaceuticals

Wave Life Sciences Ltd. - Ordinary Shares

Comments

Indivior

Indivior (NASDAQ:INDV) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell